Search results
Eczema and the COVID-19 Vaccine: Is it Safe?
Verywell Health via Yahoo News· 2 years agoCOVID-19 vaccines are safe for people who have eczema, an itchy rash that is the most common type of atopic dermatitis. The COVID-19 vaccines available...
Fact check: Monkeypox is not a side effect of the COVID-19 vaccine, experts say
USA TODAY via Yahoo News· 2 years agoThe claim: Monkeypox is a side effect of the COVID-19 vaccine Amid the recent surge of monkeypox...
How Many COVID Boosters Are There?
Verywell Health via Yahoo News· 7 months agoPast doses of the COVID vaccine will not protect you against the current strains. Current available vaccines include Pfizer-BioNTech, Moderna, and...
Travis Kelce Addresses Aaron Rodgers Calling Him 'Mr. Pfizer,' Says He 'Stands by' Getting...
People via Yahoo News· 9 months agoThe Chiefs tight end addressed the recent comment from Rodgers during a team media availability on...
A new COVID variant nicknamed "Pirola" is raising global alarm but don't freak out yet
Salon via Yahoo News· 10 months agoMutating virus variant; COVID-19; Coronavirus Getty Images/wildpixel Since the original virus that...
Lane County Public Health encourages masks as new COVID-19 subvariants rage
The Register-Guard via Yahoo News· 2 years agoThe omicron subvariant BA.5 has become the dominant strain in Lane County, making up more than 77.9%...
Emergent's (EBS) Q3 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoEmergent BioSolutions Inc. EBS reported an adjusted loss of $1.27 per share in third-quarter 2022,...
Emergent (EBS) Q1 Earnings Miss Estimates, Revenues Beat
Zacks via Yahoo Finance· 1 year agoEmergent BioSolutions Inc. EBS reported a first-quarter 2023 adjusted loss of $3.17 per share, wider...
Fact Check: Aaron Rodgers Supposedly Said He Wanted To Join 'the Team That's Going To Bring Back...
Snopes via Yahoo News· 3 months agoRyan Kang / Getty Images Claim: In an interview with The New York Times about his possible...
Emergent BioSolutions (EBS) Down 12% in a Week: Here's Why
Zacks via Yahoo Finance· 10 months agoSince the past week, Emergent BioSolutions’ EBS shares have lost 11.5% against the industry’s 1.9%...